nodes	percent_of_prediction	percent_of_DWPC	metapath
Pergolide—ADRA1D—polycystic ovary syndrome	0.319	0.412	CbGaD
Pergolide—ADRA1B—polycystic ovary syndrome	0.272	0.351	CbGaD
Pergolide—ADRA1A—polycystic ovary syndrome	0.183	0.237	CbGaD
Pergolide—Anaemia megaloblastic—Metformin—polycystic ovary syndrome	0.0044	0.115	CcSEcCtD
Pergolide—Tooth abscess—Metformin—polycystic ovary syndrome	0.00248	0.065	CcSEcCtD
Pergolide—Acidosis—Metformin—polycystic ovary syndrome	0.00187	0.0491	CcSEcCtD
Pergolide—Body temperature decreased—Metformin—polycystic ovary syndrome	0.00185	0.0485	CcSEcCtD
Pergolide—Hypothermia—Metformin—polycystic ovary syndrome	0.00185	0.0485	CcSEcCtD
Pergolide—Cabergoline—ADRA1D—polycystic ovary syndrome	0.00142	0.214	CrCbGaD
Pergolide—Cabergoline—ADRA1B—polycystic ovary syndrome	0.00121	0.183	CrCbGaD
Pergolide—Accidental injury—Metformin—polycystic ovary syndrome	0.00117	0.0307	CcSEcCtD
Pergolide—HTR2A—urine—polycystic ovary syndrome	0.00112	0.058	CbGeAlD
Pergolide—CYP3A4—urine—polycystic ovary syndrome	0.00104	0.0537	CbGeAlD
Pergolide—CYP2D6—urine—polycystic ovary syndrome	0.00102	0.0528	CbGeAlD
Pergolide—Neuropathy—Metformin—polycystic ovary syndrome	0.000974	0.0255	CcSEcCtD
Pergolide—Lisuride—ADRA1D—polycystic ovary syndrome	0.000952	0.144	CrCbGaD
Pergolide—Ergonovine—ADRA1A—polycystic ovary syndrome	0.000932	0.141	CrCbGaD
Pergolide—Ear pain—Metformin—polycystic ovary syndrome	0.000883	0.0231	CcSEcCtD
Pergolide—Injury—Metformin—polycystic ovary syndrome	0.000819	0.0215	CcSEcCtD
Pergolide—Cabergoline—ADRA1A—polycystic ovary syndrome	0.000815	0.123	CrCbGaD
Pergolide—Lisuride—ADRA1B—polycystic ovary syndrome	0.000812	0.123	CrCbGaD
Pergolide—Hypoglycaemia—Metformin—polycystic ovary syndrome	0.000772	0.0202	CcSEcCtD
Pergolide—Migraine—Metformin—polycystic ovary syndrome	0.000741	0.0194	CcSEcCtD
Pergolide—Dehydration—Metformin—polycystic ovary syndrome	0.0007	0.0183	CcSEcCtD
Pergolide—Liver function test abnormal—Metformin—polycystic ovary syndrome	0.000695	0.0182	CcSEcCtD
Pergolide—DRD5—female gonad—polycystic ovary syndrome	0.000673	0.0347	CbGeAlD
Pergolide—Abdominal distension—Metformin—polycystic ovary syndrome	0.000655	0.0172	CcSEcCtD
Pergolide—Influenza—Metformin—polycystic ovary syndrome	0.000651	0.017	CcSEcCtD
Pergolide—Pancreatitis—Metformin—polycystic ovary syndrome	0.000638	0.0167	CcSEcCtD
Pergolide—Angina pectoris—Metformin—polycystic ovary syndrome	0.000634	0.0166	CcSEcCtD
Pergolide—DRD5—endocrine gland—polycystic ovary syndrome	0.000626	0.0323	CbGeAlD
Pergolide—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.000569	0.0149	CcSEcCtD
Pergolide—HTR2B—adrenal cortex—polycystic ovary syndrome	0.000558	0.0288	CbGeAlD
Pergolide—Bradycardia—Metformin—polycystic ovary syndrome	0.00053	0.0139	CcSEcCtD
Pergolide—Rhinitis—Metformin—polycystic ovary syndrome	0.000522	0.0137	CcSEcCtD
Pergolide—Hepatitis—Metformin—polycystic ovary syndrome	0.000521	0.0136	CcSEcCtD
Pergolide—Oedema peripheral—Metformin—polycystic ovary syndrome	0.000513	0.0134	CcSEcCtD
Pergolide—ADRA1D—endocrine gland—polycystic ovary syndrome	0.000502	0.0259	CbGeAlD
Pergolide—HTR2B—endometrium—polycystic ovary syndrome	0.000498	0.0257	CbGeAlD
Pergolide—Eye disorder—Metformin—polycystic ovary syndrome	0.000487	0.0127	CcSEcCtD
Pergolide—Cabergoline—ADRB2—polycystic ovary syndrome	0.000485	0.0732	CrCbGaD
Pergolide—Chills—Metformin—polycystic ovary syndrome	0.000468	0.0122	CcSEcCtD
Pergolide—HTR2B—uterus—polycystic ovary syndrome	0.000459	0.0237	CbGeAlD
Pergolide—HTR2B—adipose tissue—polycystic ovary syndrome	0.000449	0.0231	CbGeAlD
Pergolide—Flatulence—Metformin—polycystic ovary syndrome	0.000447	0.0117	CcSEcCtD
Pergolide—Dysgeusia—Metformin—polycystic ovary syndrome	0.000444	0.0116	CcSEcCtD
Pergolide—ADRA2C—adrenal cortex—polycystic ovary syndrome	0.000439	0.0226	CbGeAlD
Pergolide—Tremor—Metformin—polycystic ovary syndrome	0.000425	0.0111	CcSEcCtD
Pergolide—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.000421	0.011	CcSEcCtD
Pergolide—Malaise—Metformin—polycystic ovary syndrome	0.000409	0.0107	CcSEcCtD
Pergolide—Syncope—Metformin—polycystic ovary syndrome	0.000407	0.0106	CcSEcCtD
Pergolide—HTR2B—adrenal gland—polycystic ovary syndrome	0.000402	0.0208	CbGeAlD
Pergolide—Palpitations—Metformin—polycystic ovary syndrome	0.000401	0.0105	CcSEcCtD
Pergolide—Loss of consciousness—Metformin—polycystic ovary syndrome	0.000399	0.0104	CcSEcCtD
Pergolide—KCNH2—endometrium—polycystic ovary syndrome	0.000397	0.0205	CbGeAlD
Pergolide—ADRA2C—endometrium—polycystic ovary syndrome	0.000392	0.0202	CbGeAlD
Pergolide—Hypertension—Metformin—polycystic ovary syndrome	0.000392	0.0103	CcSEcCtD
Pergolide—HTR1B—endocrine gland—polycystic ovary syndrome	0.000388	0.02	CbGeAlD
Pergolide—Chest pain—Metformin—polycystic ovary syndrome	0.000386	0.0101	CcSEcCtD
Pergolide—Myalgia—Metformin—polycystic ovary syndrome	0.000386	0.0101	CcSEcCtD
Pergolide—Discomfort—Metformin—polycystic ovary syndrome	0.000382	0.00999	CcSEcCtD
Pergolide—HTR2B—vagina—polycystic ovary syndrome	0.000373	0.0192	CbGeAlD
Pergolide—ADRA1A—adipose tissue—polycystic ovary syndrome	0.000371	0.0191	CbGeAlD
Pergolide—Oedema—Metformin—polycystic ovary syndrome	0.00037	0.00969	CcSEcCtD
Pergolide—Infection—Metformin—polycystic ovary syndrome	0.000368	0.00963	CcSEcCtD
Pergolide—KCNH2—uterus—polycystic ovary syndrome	0.000366	0.0189	CbGeAlD
Pergolide—DRD2—pituitary gland—polycystic ovary syndrome	0.000365	0.0188	CbGeAlD
Pergolide—Shock—Metformin—polycystic ovary syndrome	0.000364	0.00953	CcSEcCtD
Pergolide—HTR2A—embryo—polycystic ovary syndrome	0.000363	0.0187	CbGeAlD
Pergolide—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.000362	0.00949	CcSEcCtD
Pergolide—ADRA2C—uterus—polycystic ovary syndrome	0.000361	0.0186	CbGeAlD
Pergolide—HTR1A—adrenal gland—polycystic ovary syndrome	0.000361	0.0186	CbGeAlD
Pergolide—KCNH2—pituitary gland—polycystic ovary syndrome	0.000359	0.0185	CbGeAlD
Pergolide—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.000358	0.00937	CcSEcCtD
Pergolide—ADRA2C—pituitary gland—polycystic ovary syndrome	0.000355	0.0183	CbGeAlD
Pergolide—ADRA2C—adipose tissue—polycystic ovary syndrome	0.000353	0.0182	CbGeAlD
Pergolide—Anorexia—Metformin—polycystic ovary syndrome	0.000353	0.00924	CcSEcCtD
Pergolide—Hypotension—Metformin—polycystic ovary syndrome	0.000346	0.00906	CcSEcCtD
Pergolide—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.000337	0.00883	CcSEcCtD
Pergolide—ADRA1A—adrenal gland—polycystic ovary syndrome	0.000332	0.0171	CbGeAlD
Pergolide—Paraesthesia—Metformin—polycystic ovary syndrome	0.000332	0.0087	CcSEcCtD
Pergolide—Dyspnoea—Metformin—polycystic ovary syndrome	0.00033	0.00864	CcSEcCtD
Pergolide—Somnolence—Metformin—polycystic ovary syndrome	0.000329	0.00861	CcSEcCtD
Pergolide—Dyspepsia—Metformin—polycystic ovary syndrome	0.000326	0.00853	CcSEcCtD
Pergolide—Decreased appetite—Metformin—polycystic ovary syndrome	0.000322	0.00842	CcSEcCtD
Pergolide—KCNH2—adrenal gland—polycystic ovary syndrome	0.000321	0.0166	CbGeAlD
Pergolide—ADRA2C—adrenal gland—polycystic ovary syndrome	0.000317	0.0163	CbGeAlD
Pergolide—Constipation—Metformin—polycystic ovary syndrome	0.000317	0.00829	CcSEcCtD
Pergolide—HTR1A—endocrine gland—polycystic ovary syndrome	0.000313	0.0161	CbGeAlD
Pergolide—ADRA2A—endometrium—polycystic ovary syndrome	0.000313	0.0161	CbGeAlD
Pergolide—Feeling abnormal—Metformin—polycystic ovary syndrome	0.000305	0.00799	CcSEcCtD
Pergolide—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.000303	0.00792	CcSEcCtD
Pergolide—KCNH2—female gonad—polycystic ovary syndrome	0.000299	0.0154	CbGeAlD
Pergolide—KCNH2—vagina—polycystic ovary syndrome	0.000298	0.0153	CbGeAlD
Pergolide—ADRA2C—female gonad—polycystic ovary syndrome	0.000295	0.0152	CbGeAlD
Pergolide—ADRA2C—vagina—polycystic ovary syndrome	0.000294	0.0151	CbGeAlD
Pergolide—Abdominal pain—Metformin—polycystic ovary syndrome	0.000293	0.00766	CcSEcCtD
Pergolide—ADRA1A—endocrine gland—polycystic ovary syndrome	0.000288	0.0149	CbGeAlD
Pergolide—ADRA2A—uterus—polycystic ovary syndrome	0.000288	0.0149	CbGeAlD
Pergolide—ADRA2A—pituitary gland—polycystic ovary syndrome	0.000283	0.0146	CbGeAlD
Pergolide—DRD2—endocrine gland—polycystic ovary syndrome	0.000283	0.0146	CbGeAlD
Pergolide—ADRA2A—adipose tissue—polycystic ovary syndrome	0.000282	0.0145	CbGeAlD
Pergolide—KCNH2—endocrine gland—polycystic ovary syndrome	0.000278	0.0144	CbGeAlD
Pergolide—Asthenia—Metformin—polycystic ovary syndrome	0.000266	0.00695	CcSEcCtD
Pergolide—Pruritus—Metformin—polycystic ovary syndrome	0.000262	0.00686	CcSEcCtD
Pergolide—Diarrhoea—Metformin—polycystic ovary syndrome	0.000253	0.00663	CcSEcCtD
Pergolide—ADRA2A—adrenal gland—polycystic ovary syndrome	0.000253	0.013	CbGeAlD
Pergolide—Dizziness—Metformin—polycystic ovary syndrome	0.000245	0.00641	CcSEcCtD
Pergolide—HTR2A—pituitary gland—polycystic ovary syndrome	0.000241	0.0124	CbGeAlD
Pergolide—ADRA2A—female gonad—polycystic ovary syndrome	0.000236	0.0122	CbGeAlD
Pergolide—Vomiting—Metformin—polycystic ovary syndrome	0.000235	0.00616	CcSEcCtD
Pergolide—ADRA2A—vagina—polycystic ovary syndrome	0.000234	0.0121	CbGeAlD
Pergolide—Rash—Metformin—polycystic ovary syndrome	0.000233	0.00611	CcSEcCtD
Pergolide—Dermatitis—Metformin—polycystic ovary syndrome	0.000233	0.0061	CcSEcCtD
Pergolide—Headache—Metformin—polycystic ovary syndrome	0.000232	0.00607	CcSEcCtD
Pergolide—Nausea—Metformin—polycystic ovary syndrome	0.00022	0.00576	CcSEcCtD
Pergolide—ADRA2A—endocrine gland—polycystic ovary syndrome	0.000219	0.0113	CbGeAlD
Pergolide—HTR2A—adrenal gland—polycystic ovary syndrome	0.000215	0.0111	CbGeAlD
Pergolide—HTR2A—vagina—polycystic ovary syndrome	0.000199	0.0103	CbGeAlD
Pergolide—HTR2A—endocrine gland—polycystic ovary syndrome	0.000186	0.00961	CbGeAlD
Pergolide—CYP2D6—female gonad—polycystic ovary syndrome	0.000183	0.00942	CbGeAlD
Pergolide—CYP3A4—endocrine gland—polycystic ovary syndrome	0.000173	0.0089	CbGeAlD
Pergolide—CYP2D6—endocrine gland—polycystic ovary syndrome	0.00017	0.00876	CbGeAlD
Pergolide—ADRA2A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	4.97e-06	3.08e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—NCOR1—polycystic ovary syndrome	4.97e-06	3.08e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—GNAS—polycystic ovary syndrome	4.97e-06	3.08e-05	CbGpPWpGaD
Pergolide—ADRA2A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	4.95e-06	3.06e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—NCOR1—polycystic ovary syndrome	4.95e-06	3.06e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—ADRB2—polycystic ovary syndrome	4.94e-06	3.06e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling by GPCR—AKT2—polycystic ovary syndrome	4.94e-06	3.06e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—NAMPT—polycystic ovary syndrome	4.93e-06	3.05e-05	CbGpPWpGaD
Pergolide—ADRA2A—Metabolism—GNAS—polycystic ovary syndrome	4.91e-06	3.04e-05	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—IRS1—polycystic ovary syndrome	4.89e-06	3.03e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—NRG1—polycystic ovary syndrome	4.88e-06	3.02e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—CYP11A1—polycystic ovary syndrome	4.87e-06	3.01e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—ADRB2—polycystic ovary syndrome	4.86e-06	3.01e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—IRS2—polycystic ovary syndrome	4.86e-06	3.01e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—NRG1—polycystic ovary syndrome	4.86e-06	3.01e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling by GPCR—AKT2—polycystic ovary syndrome	4.84e-06	2.99e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—NCOR1—polycystic ovary syndrome	4.81e-06	2.98e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—IRS2—polycystic ovary syndrome	4.8e-06	2.97e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—IRS2—polycystic ovary syndrome	4.8e-06	2.97e-05	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—IRS1—polycystic ovary syndrome	4.79e-06	2.97e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—ADRB2—polycystic ovary syndrome	4.76e-06	2.95e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—LEP—polycystic ovary syndrome	4.76e-06	2.95e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	4.74e-06	2.94e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—NCOR1—polycystic ovary syndrome	4.74e-06	2.93e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—NRG1—polycystic ovary syndrome	4.72e-06	2.92e-05	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—IRS1—polycystic ovary syndrome	4.71e-06	2.92e-05	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—POMC—polycystic ovary syndrome	4.71e-06	2.92e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—NGFR—polycystic ovary syndrome	4.71e-06	2.91e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—LEP—polycystic ovary syndrome	4.69e-06	2.91e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—LEP—polycystic ovary syndrome	4.69e-06	2.91e-05	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—INS—polycystic ovary syndrome	4.69e-06	2.9e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—POMC—polycystic ovary syndrome	4.68e-06	2.89e-05	CbGpPWpGaD
Pergolide—ADRA2A—Metabolism—NCOR1—polycystic ovary syndrome	4.67e-06	2.89e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—PRL—polycystic ovary syndrome	4.66e-06	2.89e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—NRG1—polycystic ovary syndrome	4.65e-06	2.88e-05	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—POMC—polycystic ovary syndrome	4.61e-06	2.86e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—AKR1C3—polycystic ovary syndrome	4.6e-06	2.85e-05	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—INS—polycystic ovary syndrome	4.59e-06	2.84e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—GNAS—polycystic ovary syndrome	4.58e-06	2.84e-05	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—POMC—polycystic ovary syndrome	4.54e-06	2.81e-05	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—IGF1—polycystic ovary syndrome	4.53e-06	2.81e-05	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—AKT2—polycystic ovary syndrome	4.53e-06	2.8e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—CYP17A1—polycystic ovary syndrome	4.53e-06	2.8e-05	CbGpPWpGaD
Pergolide—DRD5—Signaling by GPCR—IL6—polycystic ovary syndrome	4.53e-06	2.8e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	4.52e-06	2.8e-05	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—INS—polycystic ovary syndrome	4.52e-06	2.79e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—GNAS—polycystic ovary syndrome	4.51e-06	2.79e-05	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—IRS1—polycystic ovary syndrome	4.5e-06	2.79e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—AKT2—polycystic ovary syndrome	4.49e-06	2.78e-05	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—IGF1—polycystic ovary syndrome	4.44e-06	2.75e-05	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—AKT2—polycystic ovary syndrome	4.43e-06	2.75e-05	CbGpPWpGaD
Pergolide—ADRA2A—Metabolism—CYP1A1—polycystic ovary syndrome	4.43e-06	2.74e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—ADRB2—polycystic ovary syndrome	4.42e-06	2.74e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—GNAS—polycystic ovary syndrome	4.42e-06	2.73e-05	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—IGF1—polycystic ovary syndrome	4.37e-06	2.7e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—NCOR1—polycystic ovary syndrome	4.37e-06	2.7e-05	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—AKT2—polycystic ovary syndrome	4.36e-06	2.7e-05	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—POMC—polycystic ovary syndrome	4.33e-06	2.68e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—IRS2—polycystic ovary syndrome	4.33e-06	2.68e-05	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—INS—polycystic ovary syndrome	4.31e-06	2.67e-05	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—SERPINE1—polycystic ovary syndrome	4.3e-06	2.66e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—NCOR1—polycystic ovary syndrome	4.3e-06	2.66e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—NRG1—polycystic ovary syndrome	4.29e-06	2.65e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—IRS1—polycystic ovary syndrome	4.24e-06	2.63e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—LEP—polycystic ovary syndrome	4.24e-06	2.62e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—NRG1—polycystic ovary syndrome	4.22e-06	2.61e-05	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—SERPINE1—polycystic ovary syndrome	4.21e-06	2.61e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—NCOR1—polycystic ovary syndrome	4.21e-06	2.6e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—IRS1—polycystic ovary syndrome	4.19e-06	2.59e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—IRS1—polycystic ovary syndrome	4.19e-06	2.59e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—IRS2—polycystic ovary syndrome	4.18e-06	2.59e-05	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—IGF1—polycystic ovary syndrome	4.17e-06	2.58e-05	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—AKT2—polycystic ovary syndrome	4.17e-06	2.58e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—IRS2—polycystic ovary syndrome	4.16e-06	2.57e-05	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—SERPINE1—polycystic ovary syndrome	4.15e-06	2.57e-05	CbGpPWpGaD
Pergolide—ADRA2A—Metabolism—MTHFR—polycystic ovary syndrome	4.13e-06	2.56e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—NRG1—polycystic ovary syndrome	4.13e-06	2.56e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	4.13e-06	2.55e-05	CbGpPWpGaD
Pergolide—ADRA2C—Metabolism—PPARG—polycystic ovary syndrome	4.12e-06	2.55e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—GNAS—polycystic ovary syndrome	4.1e-06	2.54e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—LEP—polycystic ovary syndrome	4.09e-06	2.53e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—POMC—polycystic ovary syndrome	4.09e-06	2.53e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—LEP—polycystic ovary syndrome	4.07e-06	2.52e-05	CbGpPWpGaD
Pergolide—ADRA2C—Metabolism—POMC—polycystic ovary syndrome	4.07e-06	2.52e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—INS—polycystic ovary syndrome	4.06e-06	2.52e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—IRS2—polycystic ovary syndrome	4.05e-06	2.5e-05	CbGpPWpGaD
Pergolide—ADRA2C—Metabolism—INS—polycystic ovary syndrome	4.04e-06	2.5e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—POMC—polycystic ovary syndrome	4.03e-06	2.5e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—POMC—polycystic ovary syndrome	4.03e-06	2.5e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	4.03e-06	2.5e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—INS—polycystic ovary syndrome	4.01e-06	2.48e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—INS—polycystic ovary syndrome	4.01e-06	2.48e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—IRS2—polycystic ovary syndrome	3.98e-06	2.46e-05	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—SERPINE1—polycystic ovary syndrome	3.96e-06	2.45e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—LEP—polycystic ovary syndrome	3.96e-06	2.45e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—IGF1—polycystic ovary syndrome	3.93e-06	2.43e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—AKT2—polycystic ovary syndrome	3.93e-06	2.43e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—TH—polycystic ovary syndrome	3.92e-06	2.42e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—NCOR1—polycystic ovary syndrome	3.91e-06	2.42e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	3.9e-06	2.42e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—LEP—polycystic ovary syndrome	3.9e-06	2.41e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—IGF1—polycystic ovary syndrome	3.88e-06	2.4e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—IGF1—polycystic ovary syndrome	3.88e-06	2.4e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—AKT2—polycystic ovary syndrome	3.88e-06	2.4e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—AKT2—polycystic ovary syndrome	3.88e-06	2.4e-05	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.87e-06	2.39e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—NRG1—polycystic ovary syndrome	3.84e-06	2.37e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	3.81e-06	2.36e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—IRS1—polycystic ovary syndrome	3.78e-06	2.34e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	3.73e-06	2.31e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—SERPINE1—polycystic ovary syndrome	3.68e-06	2.28e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—SERPINE1—polycystic ovary syndrome	3.68e-06	2.28e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—IRS2—polycystic ovary syndrome	3.67e-06	2.27e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—IRS1—polycystic ovary syndrome	3.65e-06	2.26e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—POMC—polycystic ovary syndrome	3.64e-06	2.25e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—IRS1—polycystic ovary syndrome	3.63e-06	2.25e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—INS—polycystic ovary syndrome	3.62e-06	2.24e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—IRS2—polycystic ovary syndrome	3.61e-06	2.24e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	3.59e-06	2.22e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—LEP—polycystic ovary syndrome	3.59e-06	2.22e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	3.58e-06	2.22e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—IRS2—polycystic ovary syndrome	3.54e-06	2.19e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—LEP—polycystic ovary syndrome	3.53e-06	2.19e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—IRS1—polycystic ovary syndrome	3.53e-06	2.19e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—POMC—polycystic ovary syndrome	3.51e-06	2.18e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—IGF1—polycystic ovary syndrome	3.5e-06	2.17e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—AKT2—polycystic ovary syndrome	3.5e-06	2.17e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—POMC—polycystic ovary syndrome	3.5e-06	2.16e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—INS—polycystic ovary syndrome	3.5e-06	2.16e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	3.48e-06	2.15e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—INS—polycystic ovary syndrome	3.48e-06	2.15e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—IRS1—polycystic ovary syndrome	3.48e-06	2.15e-05	CbGpPWpGaD
Pergolide—HTR1D—Signaling by GPCR—IL6—polycystic ovary syndrome	3.47e-06	2.15e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—LEP—polycystic ovary syndrome	3.46e-06	2.14e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—POMC—polycystic ovary syndrome	3.4e-06	2.11e-05	CbGpPWpGaD
Pergolide—HTR1B—Signaling by GPCR—IL6—polycystic ovary syndrome	3.39e-06	2.1e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—INS—polycystic ovary syndrome	3.38e-06	2.09e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—IGF1—polycystic ovary syndrome	3.38e-06	2.09e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—AKT2—polycystic ovary syndrome	3.38e-06	2.09e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—IGF1—polycystic ovary syndrome	3.36e-06	2.08e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—AKT2—polycystic ovary syndrome	3.36e-06	2.08e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	3.36e-06	2.08e-05	CbGpPWpGaD
Pergolide—ADRA2A—Metabolism—PPARG—polycystic ovary syndrome	3.35e-06	2.07e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—POMC—polycystic ovary syndrome	3.35e-06	2.07e-05	CbGpPWpGaD
Pergolide—DRD4—Signaling by GPCR—IL6—polycystic ovary syndrome	3.34e-06	2.07e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—INS—polycystic ovary syndrome	3.33e-06	2.06e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—SERPINE1—polycystic ovary syndrome	3.33e-06	2.06e-05	CbGpPWpGaD
Pergolide—ADRA2A—Metabolism—POMC—polycystic ovary syndrome	3.3e-06	2.05e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—IRS2—polycystic ovary syndrome	3.29e-06	2.03e-05	CbGpPWpGaD
Pergolide—ADRA2A—Metabolism—INS—polycystic ovary syndrome	3.29e-06	2.03e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—IGF1—polycystic ovary syndrome	3.27e-06	2.03e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—AKT2—polycystic ovary syndrome	3.27e-06	2.02e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	3.22e-06	2e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—IGF1—polycystic ovary syndrome	3.22e-06	1.99e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—AKT2—polycystic ovary syndrome	3.22e-06	1.99e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—LEP—polycystic ovary syndrome	3.22e-06	1.99e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	3.21e-06	1.99e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—IRS1—polycystic ovary syndrome	3.2e-06	1.98e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	3.2e-06	1.98e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—SERPINE1—polycystic ovary syndrome	3.19e-06	1.98e-05	CbGpPWpGaD
Pergolide—HTR2B—Signaling by GPCR—IL6—polycystic ovary syndrome	3.19e-06	1.97e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	3.18e-06	1.97e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—IRS1—polycystic ovary syndrome	3.15e-06	1.95e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—SERPINE1—polycystic ovary syndrome	3.11e-06	1.92e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—IRS1—polycystic ovary syndrome	3.09e-06	1.91e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—POMC—polycystic ovary syndrome	3.09e-06	1.91e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—INS—polycystic ovary syndrome	3.07e-06	1.9e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—SERPINE1—polycystic ovary syndrome	3.06e-06	1.89e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	3.05e-06	1.89e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—POMC—polycystic ovary syndrome	3.04e-06	1.88e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—INS—polycystic ovary syndrome	3.02e-06	1.87e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling by GPCR—IL6—polycystic ovary syndrome	3.01e-06	1.86e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	3.01e-06	1.86e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—POMC—polycystic ovary syndrome	2.97e-06	1.84e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—IGF1—polycystic ovary syndrome	2.97e-06	1.84e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling by GPCR—IL6—polycystic ovary syndrome	2.97e-06	1.84e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling by GPCR—IL6—polycystic ovary syndrome	2.97e-06	1.84e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—AKT2—polycystic ovary syndrome	2.97e-06	1.84e-05	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.96e-06	1.83e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	2.96e-06	1.83e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—INS—polycystic ovary syndrome	2.96e-06	1.83e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—IGF1—polycystic ovary syndrome	2.92e-06	1.81e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—AKT2—polycystic ovary syndrome	2.92e-06	1.81e-05	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.9e-06	1.79e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	2.89e-06	1.79e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—IRS1—polycystic ovary syndrome	2.87e-06	1.78e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—IGF1—polycystic ovary syndrome	2.86e-06	1.77e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—AKT2—polycystic ovary syndrome	2.86e-06	1.77e-05	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.85e-06	1.77e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.82e-06	1.74e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.77e-06	1.72e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—POMC—polycystic ovary syndrome	2.76e-06	1.71e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—INS—polycystic ovary syndrome	2.75e-06	1.7e-05	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.72e-06	1.69e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.72e-06	1.68e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	2.69e-06	1.67e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling by GPCR—IL6—polycystic ovary syndrome	2.68e-06	1.66e-05	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—IL6—polycystic ovary syndrome	2.67e-06	1.65e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—IGF1—polycystic ovary syndrome	2.66e-06	1.64e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—AKT2—polycystic ovary syndrome	2.66e-06	1.64e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling by GPCR—IL6—polycystic ovary syndrome	2.59e-06	1.6e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling by GPCR—IL6—polycystic ovary syndrome	2.57e-06	1.59e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.57e-06	1.59e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—TH—polycystic ovary syndrome	2.56e-06	1.59e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.53e-06	1.57e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.53e-06	1.57e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.52e-06	1.56e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling by GPCR—IL6—polycystic ovary syndrome	2.5e-06	1.55e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	2.49e-06	1.54e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling by GPCR—IL6—polycystic ovary syndrome	2.46e-06	1.52e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	2.34e-06	1.45e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.29e-06	1.42e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling by GPCR—IL6—polycystic ovary syndrome	2.27e-06	1.41e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling by GPCR—IL6—polycystic ovary syndrome	2.23e-06	1.38e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.21e-06	1.37e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.2e-06	1.36e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling by GPCR—IL6—polycystic ovary syndrome	2.19e-06	1.35e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	2.18e-06	1.35e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	2.15e-06	1.33e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—INS—polycystic ovary syndrome	2.14e-06	1.33e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.14e-06	1.32e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.1e-06	1.3e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	2.09e-06	1.29e-05	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—IL6—polycystic ovary syndrome	2.05e-06	1.27e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—IL6—polycystic ovary syndrome	2.03e-06	1.26e-05	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—IL6—polycystic ovary syndrome	2e-06	1.24e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	1.99e-06	1.23e-05	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—IL6—polycystic ovary syndrome	1.97e-06	1.22e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.94e-06	1.2e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.91e-06	1.18e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	1.89e-06	1.17e-05	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—IL6—polycystic ovary syndrome	1.88e-06	1.17e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.87e-06	1.16e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—IL6—polycystic ovary syndrome	1.78e-06	1.1e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	1.76e-06	1.09e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—IL6—polycystic ovary syndrome	1.75e-06	1.08e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—IL6—polycystic ovary syndrome	1.75e-06	1.08e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.74e-06	1.07e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—IL6—polycystic ovary syndrome	1.58e-06	9.79e-06	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—IL6—polycystic ovary syndrome	1.53e-06	9.45e-06	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—IL6—polycystic ovary syndrome	1.52e-06	9.41e-06	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—IL6—polycystic ovary syndrome	1.48e-06	9.15e-06	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—IL6—polycystic ovary syndrome	1.45e-06	9e-06	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	1.43e-06	8.83e-06	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	1.41e-06	8.71e-06	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—INS—polycystic ovary syndrome	1.4e-06	8.66e-06	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—IL6—polycystic ovary syndrome	1.34e-06	8.3e-06	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—IL6—polycystic ovary syndrome	1.32e-06	8.17e-06	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—IL6—polycystic ovary syndrome	1.29e-06	8e-06	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—IL6—polycystic ovary syndrome	1.2e-06	7.43e-06	CbGpPWpGaD
